187 related articles for article (PubMed ID: 6385831)
1. [Comparative evaluation of the clinical effectiveness of 3 preparations of E. coli L-asparaginase].
Kondrat'eva NA
Antibiotiki; 1984 Jul; 29(7):527-31. PubMed ID: 6385831
[TBL] [Abstract][Full Text] [Related]
2. [L-asparaginase study results (phase II of the clinical trials)].
Kondrat'eva NA; Kruglova GV; Lorie IuI; Koshel' IV; Kurmashov VI
Antibiotiki; 1980 Sep; 25(9):686-9. PubMed ID: 6998370
[TBL] [Abstract][Full Text] [Related]
3. [Results of a cooperative clinical study of Soviet L-asparaginase from E. coli].
Kondrat'eva NA; Lorie IuI; Kruglova GV; Vorob'ev AI; Brilliant MD
Probl Gematol Pereliv Krovi; 1980 Jul; 25(7):3-9. PubMed ID: 6995975
[No Abstract] [Full Text] [Related]
4. [Preliminary results of the clinical study of a Soviet--produced L-asparaginase from E. coli].
Kondrat'eva NA; Lorie IlI ; Kruglova GV; Vorob'ev AI; Koshel' IV
Antibiotiki; 1977 Sep; 22(9):852-7. PubMed ID: 334060
[No Abstract] [Full Text] [Related]
5. [Effectiveness of various methods of chemotherapy of lymphosarcoma].
Abdyldaev RA; Kruglova GV
Ter Arkh; 1984; 56(6):70-5. PubMed ID: 6382672
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and drug monitoring of L-asparaginase treatment.
Boos J
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):96-8. PubMed ID: 9088996
[TBL] [Abstract][Full Text] [Related]
7. L-asparaginase in treatment of acute leukemia in children.
Misíková Z; Cáp J
Neoplasma; 1978; 25(1):133-9. PubMed ID: 273152
[TBL] [Abstract][Full Text] [Related]
8. [Comparative pharmacokinetic study of two different ways of using L-asparaginase as the main drug in combination chemotherapy].
Wang Y; Jiang H; Xie X
Zhonghua Xue Ye Xue Za Zhi; 1999 Nov; 20(11):589-91. PubMed ID: 11721378
[TBL] [Abstract][Full Text] [Related]
9. [Clinical experiences with adrenaline as therapy and prevention of E. coli-L-asparaginase-induced anaphylaxis].
Schwinger W; Urban C; Lackner H
Klin Padiatr; 1992; 204(4):274-6. PubMed ID: 1518264
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
Yong W; Zheng W; Zhang Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):773-5. PubMed ID: 11798962
[TBL] [Abstract][Full Text] [Related]
12. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE
Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
[TBL] [Abstract][Full Text] [Related]
13. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
Appel IM; Hop WC; Pieters R
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):139-46. PubMed ID: 16479196
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations.
Boos J; Werber G; Ahlke E; Schulze-Westhoff P; Nowak-Göttl U; Würthwein G; Verspohl EJ; Ritter J; Jürgens H
Eur J Cancer; 1996 Aug; 32A(9):1544-50. PubMed ID: 8911116
[TBL] [Abstract][Full Text] [Related]
15. [Results of a cooperative clinical study of leumase].
Kondrat'eva NA; Lorie IuI; Kruglova GV; Vorob'ev AI; Brilliant MD
Probl Gematol Pereliv Krovi; 1980 Aug; 25(8):5-8. PubMed ID: 6997864
[No Abstract] [Full Text] [Related]
16. [Attempts at treatment of acute leukemia with L-asparaginase].
Lawkowicz W; Krzemińska-Lawkowiczowa ; Kozlowska J; Polubiec A; Derulska D; Kolakowska-Polubiec K; Litwin J; Rokicka R
Acta Haematol Pol; 1971; 2(4):305-10. PubMed ID: 5293225
[No Abstract] [Full Text] [Related]
17. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of L-asparaginase].
Benkö S
Orv Hetil; 1969 Aug; 110(35):2019-23. PubMed ID: 4900161
[No Abstract] [Full Text] [Related]
19. L-asparaginase related hyperglycemia.
Iyer RS; Rao SR; Pai S; Advani SH; Magrath IT
Indian J Cancer; 1993 Jun; 30(2):72-6. PubMed ID: 8225380
[TBL] [Abstract][Full Text] [Related]
20. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
